The involvement of galectin-2 in cardiovascular events was first implicated from the identification of galectin-2 as a binding partner of lymphotoxin-α, a cytokine that is involved in the pathogenesis of myocardial infarction (MI), in COS7 non-steroidogenic and U937 pro-monocytic cells [32]. The gene discussed is LGALS2; the disease is myocardial infarction.